Clinical Trial Update: Clinical Outcomes in WHO Type I Anovulatory Women Using r-hFSH+r-hLH in a 2:1 Ratio or hMG-HP [NA]

View source ↗

Summary

Clinical trial outcomes for WHO Type I anovulatory women treated with recombinant FSH and LH in a 2:1 ratio or with HP-hMG were reported; the study has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadotropic Hypogonadism

Drugs mentioned

• Human menopausal gonadotropin (human menopausal gonadotropin)
• Recombinant human luteinizing hormone (lutropin alfa)
• recombinant human follicle-stimulating hormone (follitropin alfa)

Snippet

Sponsor: Centro Riproduzione e Andrologia | Conditions: Hypogonadotropic Hypogonadism | NA | Status: COMPLETED